Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

Research Progress of TLR9 Inherent Signaling Pathways in Tumor Cells

Research progress on function and regulation of TLR9 signaling pathway

TLR4 Signaling Promotes Immune Escape of Human Lung Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance.

Toll-like Receptor 3 and Tumor Immunity

Toll-like receptor 9 in tumorigenesis and tumor therapy

TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell in Vivo

Toll-Like Receptor 9 Agonist Inhibits Er Alpha-Mediated Transactivation by Activating Nf-Kappa B in Breast Cancer Cell Lines

MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression Via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer.

Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis.

Functional Expression of TLR9 is Associated to the Metastatic Potential of Human Lung Cancer Cell

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

Heterogeneity of Toll-like Receptor 9 Signaling in B Cell Malignancies and Its Potential Therapeutic Application

Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy

Toll-like Receptor and Tumor Immunity

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity

Dual Character of Toll-like Receptor Signaling: Pro-tumorigenic Effects and Anti-Tumor Functions

Selective Up-Regulation of Cdk2 is Critical for Tlr9 Signaling Stimulated Proliferation of Human Lung Cancer Cell

CpG Oligonucleotides Activating Toll-Like Receptor 9 Promotes Invasion of Breast Cancer Cells

Functional expression of TLR9 in esophageal cancer

Regulation Of Migration And Invasion By Toll-Like Receptor-9 Signaling Network In Prostate Cancer

Activation of Toll-Like Receptor-9 Promotes Cellular Migration Via Up-Regulating MMP-2 Expression in Oral Squamous Cell Carcinoma